NO-Donating Carbonic Anhydrase Inhibitors (NicOx/Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNO-Donating Carbonic Anhydrase Inhibitors (NicOx/Pfizer)
Drug Alias NameNO-donating dorzolamide analogs (NicOx/Pfizer)Nitric Oxide-Donating Carbonic Anhydrase Inhibitors (NicOx/Pfizer)NCX-201NCX-250NCX-274 +[8] 
ClassificationSmall molecules
Mechanisms of ActionNitric oxide donorsCarbonic anhydrases inhibitors
TargetsCarbonic anhydrases
Therapy Area/IndicationsGlaucoma, Open-Angle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNicox SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNicox SAPfizer Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma, Open-Angle

Other Information

ATC CodeN/A
Related LinksN/A